shaping the future of healthcare together
Supporting Life Science Companies Developing Innovation on a Global Scale
CS Life Science Invest helps international life sciences startups, emerging and later stage companies that seek access to the European market with their company development.
This high-end life sciences consulting and investment firm runs programs for industry organizations and also offers support directly to companies.
CSLSi operates out of Europe and has international access to talent and to a vast network of industry leaders, investors, and other relevant stakeholders.
Life Science Advisory
With our Partner Network
Our international expert network consists of experienced Biotech, MedTech, and Pharma Professionals.
Our partner network acquired profound insights into various industries. This expertise facilitates investments in private and public companies as Angel Investors or structure Instruments similar to Wikifolio.
Our SpecialtiesWhat we can do for you.
Get In Touch For a Consultation
Executive Board Members
advisory Board Members
Strategic Consulting – E3=BMC2
Due Diligence, Evaluation
Mergers & Acquisitions
Financial and Growth Strategy
Christian Soschner – passion for health and innovation. Christian supports life science companies with his network to develop, finance and commercialize innovation on a global scale. He graduated from the University of Graz, specialized in Economy and Finance. He also holds degrees in communication and business coaching. As an entrepreneur Christian has 30 years of experience in developing and improving business models.
Trained in economics and psychology, he worked in management positions at listed companies in various industries. Since 2006 he has served as executive and advisory board member for companies in drug development, diagnostics, medical devices and digital health. He has supported writing success stories for companies like Themis Bioscience or Nabriva. As an executive board member, advisory board member, business angel, or coach he helps developing life science companies from spin out to IPO or M&A to the pharmaceutical industry.
Get In Touch
CS Life Science Invest
Mag. Christian Soschner
A – 1050 Vienna